top of page
Cancer Vaccine Institute News


Dr. Natasha Hunter Named 2026 Athena Endowed Award Recipient
Photo Credits: Fred Hutch Dr. Natasha (Tasha) Hunter , Cancer Vaccine Institute Director of Clinical Trials, has been selected as the recipient of the 2026 Athena Endowed Award for Excellence in Breast Cancer Research. The Athena Award was established to recognize an early career researcher making the greatest contribution during the past year toward advancing research to improve the prevention, detection, diagnosis and/or treatment of breast cancer. Read more about Dr. Hunte

Sarah White
Mar 16


CVI’s Dr. Andrew Coveler named as one of 2021 Seattle Met’s Top Doctors!
Dr. Andrew Coveler is the Interim Director of Clinical Trials at the Cancer Vaccine Institute. He was selected by his peers as one of...
luciafw
Sep 16, 2021
Blog: Blog2
bottom of page
